139 related articles for article (PubMed ID: 33777195)
1. Long non-coding RNA LINC00173 enhances cisplatin resistance in hepatocellular carcinoma via the microRNA-641/RAB14 axis.
Zhao G; Zhang A; Sun S; Ding Y
Oncol Lett; 2021 May; 21(5):371. PubMed ID: 33777195
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-361-5p induces hepatocellular carcinoma cell apoptosis and enhances drug sensitivity by targeting MAP3K9.
Ren Q; Xiao X; Leng X; Zhang Q; Zhou X; Ren Z; Xiao H
Exp Ther Med; 2021 Jun; 21(6):574. PubMed ID: 33850546
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of
Liu Z; Dang C; Xing E; Zhao M; Shi L; Sun J
DNA Cell Biol; 2019 Nov; 38(11):1366-1373. PubMed ID: 31633393
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
Wang L; Shang X; Feng Q
Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
[TBL] [Abstract][Full Text] [Related]
6. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA OIP5-AS1 contributes to cisplatin resistance of oral squamous cell carcinoma through the miR-27b-3p/TRIM14 axis.
Xiao Z; Li J; Jin Q; Liu D
Exp Ther Med; 2021 Apr; 21(4):408. PubMed ID: 33692839
[TBL] [Abstract][Full Text] [Related]
8. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
9. PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis.
Guo Y; Yue P; Wang Y; Chen G; Li Y
Biomed Pharmacother; 2019 Oct; 118():109255. PubMed ID: 31352238
[TBL] [Abstract][Full Text] [Related]
10. HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma.
Li H; Huang J; Yu S; Li H; Zhou Y; Wu Q
Oncol Lett; 2021 Jun; 21(6):493. PubMed ID: 33968209
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
12. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
Yi D; Xu L; Wang R; Lu X; Sang J
Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043
[TBL] [Abstract][Full Text] [Related]
13. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA
Yang F; Lei P; Zeng W; Gao J; Wu N
Cancer Manag Res; 2020; 12():3131-3144. PubMed ID: 32440211
[TBL] [Abstract][Full Text] [Related]
16. KCNQ1OT1 promotes migration and inhibits apoptosis by modulating miR-185-5p/Rab14 axis in oral squamous cell carcinoma.
Bao Q; Liao X; Li R; Ding N
Dev Growth Differ; 2019 Dec; 61(9):466-474. PubMed ID: 31755091
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a.
Li Y; Lv S; Ning H; Li K; Zhou X; Xv H; Wen H
Biomed Pharmacother; 2018 Dec; 108():1775-1782. PubMed ID: 30372881
[TBL] [Abstract][Full Text] [Related]
18. SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381.
Mi H; Wang X; Wang F; Li L; Zhu M; Wang N; Xiong Y; Gu Y
Onco Targets Ther; 2020; 13():657-666. PubMed ID: 32021307
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA LINC00173 Contributes to the Growth, Invasiveness and Chemo-Resistance of Colorectal Cancer Through Regulating miR-765/PLP2 Axis.
Yu Y; Lu X; Yang C; Yin F
Cancer Manag Res; 2020; 12():3363-3369. PubMed ID: 32494200
[TBL] [Abstract][Full Text] [Related]
20. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]